Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Miyamoto

Showing results (61-70 of 132) with videos related to

Pageof 14
Sort By:
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|August 19, 2017
Integration of DPC and clinical microbiological data in Japan reveals importance of confirming a negative follow-up blood culture in patients with MRSA bacteremiaNaoki Miyamoto, Koji Yahara, Rie Horita, et al.
AME Case Reports|April 13, 2026
Severe edema as an immune-related adverse event following nivolumab therapy: a case reportNaoki Miyamoto, Ayaka Tsuji, Shiori Matsui, et al.
Journal of Cardiothoracic Surgery|May 16, 2024
Robot-assisted thoracoscopic resection of a posterior mediastinal tumor with immunoglobulin G4-related disease: a case reportTaihei Takeuchi, Hiromitsu Takizawa, Yoshimi Bando, et al.
Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy|September 14, 2019
Percutaneous insertion of hepatic fiducial true-spherical markers for real-time adaptive radiotherapyRyo Morita, Daisuke Abo, Yusuke Sakuhara, et al.
Bioorganic & Medicinal Chemistry|September 14, 2010
Design, synthesis, and evaluation of 5-methyl-4-phenoxy-5H-pyrrolo[3,2-d]pyrimidine derivatives: novel VEGFR2 kinase inhibitors binding to inactive kinase conformationYuya Oguro, Naoki Miyamoto, Kengo Okada, et al.
Gland Surgery|November 15, 2024
Lenvatinib treatment strategy for thyroid carcinoma with malignant pleurisy: a case reportShinichi Sakamoto, Mariko Misaki, Keisuke Fujimoto, et al.
Molecular Cancer Therapeutics|April 4, 2013
A novel inhibitor of c-Met and VEGF receptor tyrosine kinases with a broad spectrum of in vivo antitumor activitiesYoshiko Awazu, Kazuhide Nakamura, Akio Mizutani, et al.
ACS Medicinal Chemistry Letters|October 24, 2017
Targeting the Allosteric Site of Oncoprotein BCR-ABL as an Alternative Strategy for Effective Target Protein DegradationKenichiro Shimokawa, Norihito Shibata, Tomoya Sameshima, et al.
Journal of Medicinal Chemistry|March 17, 2006
Highly potent and orally active CCR5 antagonists as anti-HIV-1 agents: synthesis and biological activities of 1-benzazocine derivatives containing a sulfoxide moietyMasaki Seto, Katsuji Aikawa, Naoki Miyamoto, et al.
Journal of Radiation Research|May 5, 2017
A simulation study on the dosimetric benefit of real-time motion compensation in spot-scanning proton therapy for prostateYusuke Fujii, Taeko Matsuura, Seishin Takao, et al.
Pageof 14

Showing results (61-70 of 132) with videos related to

Sort By:
Pageof 14
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|August 19, 2017
Integration of DPC and clinical microbiological data in Japan reveals importance of confirming a negative follow-up blood culture in patients with MRSA bacteremiaNaoki Miyamoto, Koji Yahara, Rie Horita, et al.
AME Case Reports|April 13, 2026
Severe edema as an immune-related adverse event following nivolumab therapy: a case reportNaoki Miyamoto, Ayaka Tsuji, Shiori Matsui, et al.
Journal of Cardiothoracic Surgery|May 16, 2024
Robot-assisted thoracoscopic resection of a posterior mediastinal tumor with immunoglobulin G4-related disease: a case reportTaihei Takeuchi, Hiromitsu Takizawa, Yoshimi Bando, et al.
Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy|September 14, 2019
Percutaneous insertion of hepatic fiducial true-spherical markers for real-time adaptive radiotherapyRyo Morita, Daisuke Abo, Yusuke Sakuhara, et al.
Bioorganic & Medicinal Chemistry|September 14, 2010
Design, synthesis, and evaluation of 5-methyl-4-phenoxy-5H-pyrrolo[3,2-d]pyrimidine derivatives: novel VEGFR2 kinase inhibitors binding to inactive kinase conformationYuya Oguro, Naoki Miyamoto, Kengo Okada, et al.
Gland Surgery|November 15, 2024
Lenvatinib treatment strategy for thyroid carcinoma with malignant pleurisy: a case reportShinichi Sakamoto, Mariko Misaki, Keisuke Fujimoto, et al.
Molecular Cancer Therapeutics|April 4, 2013
A novel inhibitor of c-Met and VEGF receptor tyrosine kinases with a broad spectrum of in vivo antitumor activitiesYoshiko Awazu, Kazuhide Nakamura, Akio Mizutani, et al.
ACS Medicinal Chemistry Letters|October 24, 2017
Targeting the Allosteric Site of Oncoprotein BCR-ABL as an Alternative Strategy for Effective Target Protein DegradationKenichiro Shimokawa, Norihito Shibata, Tomoya Sameshima, et al.
Journal of Medicinal Chemistry|March 17, 2006
Highly potent and orally active CCR5 antagonists as anti-HIV-1 agents: synthesis and biological activities of 1-benzazocine derivatives containing a sulfoxide moietyMasaki Seto, Katsuji Aikawa, Naoki Miyamoto, et al.
Journal of Radiation Research|May 5, 2017
A simulation study on the dosimetric benefit of real-time motion compensation in spot-scanning proton therapy for prostateYusuke Fujii, Taeko Matsuura, Seishin Takao, et al.
Pageof 14